{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T15:12:13Z","timestamp":1775574733011,"version":"3.50.1"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s40121-026-01306-7","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T10:26:25Z","timestamp":1770632785000},"page":"921-939","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Outpatient Parenteral Antimicrobial Therapy (OPAT) in Italy: A Scoping Review"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7926-7581","authenticated-orcid":false,"given":"Chiara","family":"Moreal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Giuliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Prataviera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Fantoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Mezzadri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Menozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meri","family":"Marin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raul","family":"Cetatean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Sora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena Rosselli","family":"Del Turco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Tumietto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Moracas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo","family":"Guarino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Vecchio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Odone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vilma","family":"Urban\u010di\u010d","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alvisa","family":"Palese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Tascini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"issue":"1","key":"1306_CR1","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciy745","volume":"68","author":"AH Norris","year":"2019","unstructured":"Norris AH, Shrestha NK, Allison GM, Keller SC, Bhavan KP, Zurlo JJ, et al. 2018 Infectious Diseases Society of America Clinical Practice Guideline for the management of outpatient parenteral antimicrobial therapy. Clin Infect Dis. 2019;68(1):e1-35.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"1306_CR2","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1542\/peds.54.3.358","volume":"54","author":"RW Rucker","year":"1974","unstructured":"Rucker RW, Harrison GM. Outpatient intravenous medications in the management of cystic fibrosis. Pediatrics. 1974;54(3):358\u201360.","journal-title":"Pediatrics"},{"issue":"3","key":"1306_CR3","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.ijantimicag.2015.07.001","volume":"46","author":"DN Williams","year":"2015","unstructured":"Williams DN, Baker CA, Kind AC, Sannes MR. The history and evolution of outpatient parenteral antibiotic therapy (OPAT). Int J Antimicrob Agents. 2015;46(3):307\u201312.","journal-title":"Int J Antimicrob Agents"},{"key":"1306_CR4","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jss.2020.11.062","volume":"260","author":"B Sen-Crowe","year":"2021","unstructured":"Sen-Crowe B, Sutherland M, McKenney M, Elkbuli A. A closer look into global hospital beds capacity and resource shortages during the COVID-19 pandemic. J Surg Res. 2021;260:56\u201363.","journal-title":"J Surg Res"},{"issue":"8","key":"1306_CR5","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.13216","volume":"72","author":"S Sriskandarajah","year":"2018","unstructured":"Sriskandarajah S, Hobbs J, Roughead E, Ryan M, Reynolds K. Safety and effectiveness of \u2018hospital in the home\u2019 and \u2018outpatient parenteral antimicrobial therapy\u2019 in different age groups: a systematic review of observational studies. Int J Clin Pract. 2018;72(8):e13216.","journal-title":"Int J Clin Pract"},{"issue":"1","key":"1306_CR6","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S1473-3099(18)30605-4","volume":"19","author":"A Cassini","year":"2019","unstructured":"Cassini A, H\u00f6gberg LD, Plachouras D, Quattrocchi A, Hoxha A, Simonsen GS, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect Dis. 2019;19(1):56\u201366.","journal-title":"Lancet Infect Dis"},{"key":"1306_CR7","unstructured":"Ricchizzi E, Sasdelli E, Leucci AC, Fabbri E, Caselli L, Latour K, et al. Incidence of health-care-associated infections in long-term care facilities in nine European countries: a 12-month, prospective, longitudinal cohort study. Lancet Infect Dis [Internet]. 2025 June 16 [cited 2025 Sept 16]. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1473309925002178."},{"issue":"4","key":"1306_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-013560","volume":"7","author":"ED Mitchell","year":"2017","unstructured":"Mitchell ED, Czoski Murray C, Meads D, Minton J, Wright J, Twiddy M. Clinical and cost-effectiveness, safety and acceptability of community intravenous antibiotic service models: CIVAS systematic review. BMJ Open. 2017;7(4):e013560.","journal-title":"BMJ Open"},{"issue":"6","key":"1306_CR9","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1093\/cid\/ciaf146","volume":"80","author":"AV Yamshchikov","year":"2025","unstructured":"Yamshchikov AV, Burgoyne C, Calisir N, Goins P, Heffer T, Munsiff SS. Quantifying and financing the nonbillable workload of outpatient parenteral antimicrobial therapy (OPAT)\u2014a model for assessing and supporting staffing needs for OPAT Programs. Clin Infect Dis. 2025;80(6):1221\u20138.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"1306_CR10","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1080\/14737167.2019.1541404","volume":"19","author":"EM Psaltikidis","year":"2019","unstructured":"Psaltikidis EM, Silva END, Moretti ML, Trabasso P, Stucchi RSB, Aoki FH, et al. Cost-utility analysis of outpatient parenteral antimicrobial therapy (OPAT) in the Brazilian national health system. Expert Rev Pharmacoecon Outcomes Res. 2019;19(3):341\u201352.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"8","key":"1306_CR11","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1093\/jac\/dkx123","volume":"72","author":"A Vargas-Palacios","year":"2017","unstructured":"Vargas-Palacios A, Meads DM, Twiddy M, Czoski Murray C, Hulme C, Mitchell ED, et al. Cost-effectiveness of outpatient parenteral antibiotic therapy: a simulation modelling approach. J Antimicrob Chemother. 2017;72(8):2392\u2013400.","journal-title":"J Antimicrob Chemother"},{"key":"1306_CR12","volume":"11","author":"H Bao","year":"2024","unstructured":"Bao H, Igwilo-Alaneme R, Sonia F, Cowman K, Kahn M, Nori P. Dalbavancin as an alternative to traditional outpatient parenteral antimicrobial therapy for deep gram-positive infections\u2014an observational, retrospective review. Ther Adv Infect Dis. 2024;11:20499361241245523.","journal-title":"Ther Adv Infect Dis"},{"issue":"9","key":"1306_CR13","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1093\/jac\/dkae177","volume":"79","author":"ZT Wolie","year":"2024","unstructured":"Wolie ZT, Roberts JA, Gilchrist M, McCarthy K, Sime FB. Current practices and challenges of outpatient parenteral antimicrobial therapy: a narrative review. J Antimicrob Chemother. 2024;79(9):2083\u2013102.","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"1306_CR14","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1093\/jac\/dkq445","volume":"66","author":"CL Mackintosh","year":"2011","unstructured":"Mackintosh CL, White HA, Seaton RA. Outpatient parenteral antibiotic therapy (OPAT) for bone and joint infections: experience from a UK teaching hospital-based service. J Antimicrob Chemother. 2011;66(2):408\u201315.","journal-title":"J Antimicrob Chemother"},{"issue":"01","key":"1306_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1055\/a-2288-7187","volume":"163","author":"A Strassburg","year":"2025","unstructured":"Strassburg A, Weber AT, Kluba T. Etablierung der ambulanten intraven\u00f6sen Antibiotikatherapie (APAT) bei Patienten mit komplizierten Periimplantatinfektionen. Z Orthop Unfall. 2025;163(01):35\u201343.","journal-title":"Z Orthop Unfall"},{"key":"1306_CR16","doi-asserted-by":"publisher","unstructured":"Baddour LM, Wilson WR, Bayer AS, Fowler VG, Bolger AF, Levison ME, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the committee on rheumatic fever, endocarditis, and kawasaki disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: Endorsed by the Infectious Diseases Society of America. Circulation [Internet]. 2005 June 14 [cited 2025 Oct 1];111(23). Available from: https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.165564.","DOI":"10.1161\/CIRCULATIONAHA.105.165564"},{"issue":"44","key":"1306_CR17","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1093\/eurheartj\/ehv319","volume":"36","author":"G Habib","year":"2015","unstructured":"Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, et al. 2015 ESC guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European Society of Cardiology (ESC) Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36(44):3075\u2013128.","journal-title":"Eur Heart J"},{"issue":"10","key":"1306_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2025.102938","volume":"18","author":"SA Mohammed","year":"2025","unstructured":"Mohammed SA, Roberts N, Nicol\u00e1s D, Unwin S, Cotta M, Roberts JA, et al. Implementation of outpatient parenteral antimicrobial therapy program in the contemporary health care system: a narrative review of the evidence. J Infect Public Health. 2025;18(10):102938.","journal-title":"J Infect Public Health"},{"issue":"5","key":"1306_CR19","doi-asserted-by":"publisher","first-page":"ofad173","DOI":"10.1093\/ofid\/ofad173","volume":"10","author":"LJ Van Anglen","year":"2023","unstructured":"Van Anglen LJ, Schroeder CP, Couch KA. A real-world multicenter outpatient experience of ceftolozane\/tazobactam. Open Forum Infect Dis. 2023;10(5):ofad173.","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"1306_CR20","doi-asserted-by":"publisher","first-page":"dlz026","DOI":"10.1093\/jacamr\/dlz026","volume":"1","author":"ALN Chapman","year":"2019","unstructured":"Chapman ALN, Patel S, Horner C, Green H, Guleri A, Hedderwick S, et al. Updated good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults and children in the UK. JAC-Antimicrob Resist. 2019;1(2):dlz026.","journal-title":"JAC-Antimicrob Resist."},{"issue":"2","key":"1306_CR21","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1080\/1120009X.2023.2277507","volume":"36","author":"OC Durojaiye","year":"2024","unstructured":"Durojaiye OC, Cole J, Kritsotakis EI. Effectiveness and safety of a disposable elastomeric continuous infusion pump for outpatient parenteral antimicrobial therapy (OPAT) in a UK setting. J Chemother. 2024;36(2):119\u201326.","journal-title":"J Chemother"},{"issue":"2","key":"1306_CR22","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.ijantimicag.2019.04.008","volume":"54","author":"J Hatcher","year":"2019","unstructured":"Hatcher J, Costelloe C, Cele R, Viljanen A, Samarasinghe D, Satta G, et al. Factors associated with successful completion of outpatient parenteral antibiotic therapy (OPAT): a 10-year review from a large West London service. Int J Antimicrob Agents. 2019;54(2):207\u201314.","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"1306_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2024.107263","volume":"64","author":"SA Mohammed","year":"2024","unstructured":"Mohammed SA, Roberts JA, Cotta MO, Rogers B, Pollard J, Assefa GM, et al. Safety and efficacy of outpatient parenteral antimicrobial therapy: a systematic review and meta-analysis of randomized clinical trials. Int J Antimicrob Agents. 2024;64(2):107263.","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"1306_CR24","doi-asserted-by":"publisher","first-page":"dlae111","DOI":"10.1093\/jacamr\/dlae111","volume":"6","author":"P Reidy","year":"2024","unstructured":"Reidy P, Breslin T, Muldoon E. Outpatient parenteral antimicrobial therapy (OPAT) across the world: a comparative analysis\u2014what lessons can we learn? JAC-Antimicrob Resist. 2024;6(4):dlae111.","journal-title":"JAC-Antimicrob Resist."},{"issue":"8","key":"1306_CR25","doi-asserted-by":"publisher","first-page":"ofaa309","DOI":"10.1093\/ofid\/ofaa309","volume":"7","author":"CG Rivera","year":"2020","unstructured":"Rivera CG, Mahoney MV, Stevens RW, Abu Saleh O. Out of sight but not out of mind: caring for patients receiving OPAT during the SARS-CoV-2 pandemic. Open Forum Infect Dis. 2020;7(8):ofaa309.","journal-title":"Open Forum Infect Dis"},{"key":"1306_CR26","unstructured":"Presidenza della Repubblica Italiana. Regulation on the distribution of medicines by hospital pharmacies, n.384. 1992."},{"key":"1306_CR27","unstructured":"De Belvis A, Meregaglia M, Morsella A, Adduci A, Perilli A, Cascini F, et al. Italy: Health System Summary, 2024. Copenhagen: European Observatory on Health Systems and Policies, WHO Regional Office for Europe; 2024."},{"key":"1306_CR28","doi-asserted-by":"crossref","unstructured":"Aromataris E, Lockwood C, Porritt K, Pilla B, Jordan Z, editors. JBI manual for evidence synthesis [Internet]. JBI; 2024 [cited 2024 Aug 18]. Available from: https:\/\/jbi-global-wiki.refined.site\/space\/MANUAL.","DOI":"10.46658\/JBIMES-24-01"},{"issue":"7","key":"1306_CR29","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, O\u2019Brien KK, Colquhoun H, Levac D, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467\u201373.","journal-title":"Ann Intern Med"},{"issue":"1","key":"1306_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan\u2014a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210.","journal-title":"Syst Rev"},{"key":"1306_CR31","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"29","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;29:n71.","journal-title":"BMJ"},{"issue":"3","key":"1306_CR32","doi-asserted-by":"publisher","first-page":"dlaf066","DOI":"10.1093\/jacamr\/dlaf066","volume":"7","author":"S Babich","year":"2025","unstructured":"Babich S, Cojutti PG, Gatti M, Pea F, Di Bella S, Monticelli J. Feasibility of 24 h continuous-infusion cefiderocol administered by elastomeric pump in attaining an aggressive PK\/PD target in the treatment of NDM-producing Klebsiella pneumoniae otomastoiditis. JAC-Antimicrob Resist. 2025;7(3):dlaf066.","journal-title":"JAC-Antimicrob Resist."},{"issue":"1","key":"1306_CR33","first-page":"88","volume":"12","author":"S Esposito","year":"2000","unstructured":"Esposito S, Noviello S, Ianniello F, D\u2019Errico G. Ceftazidime for outpatient parenteral antibiotic therapy (OPAT) of chronic suppurative otitis media due to Pseudomonas aeruginosa. J Chemother. 2000;12(1):88\u201393.","journal-title":"J Chemother"},{"issue":"1","key":"1306_CR34","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ijantimicag.2014.04.007","volume":"44","author":"C Eckmann","year":"2014","unstructured":"Eckmann C, Lawson W, Nathwani D, Solem CT, Stephens JM, Macahilig C, et al. Antibiotic treatment patterns across Europe in patients with complicated skin and soft-tissue infections due to meticillin-resistant Staphylococcus aureus: a plea for implementation of early switch and early discharge criteria. Int J Antimicrob Agents. 2014;44(1):56\u201364.","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"1306_CR35","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.ijantimicag.2004.06.004","volume":"24","author":"S Esposito","year":"2004","unstructured":"Esposito S, Noviello S, Leone S, Tice A, Seibold G, Nathwani D, et al. Outpatient parenteral antibiotic therapy (OPAT) in different countries: a comparison. Int J Antimicrob Agents. 2004;24(5):473\u20138.","journal-title":"Int J Antimicrob Agents"},{"key":"1306_CR36","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1111\/j.1469-0691.2011.03477.x","volume":"17","author":"A Gonzalez-Ruiz","year":"2011","unstructured":"Gonzalez-Ruiz A, Dailiana Z, Gargalianos-Kakolyris P, Gonz\u00e1lez-Ramallo VJ, Seaton RA, Prisco V, et al. Outpatient and inpatient parenteral antibiotic therapy with daptomycin in a large non-interventional study: reducing total therapy costs. Clin Microbiol Infect. 2011;17:S1-107.","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"1306_CR37","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-031356","volume":"9","author":"U Restelli","year":"2019","unstructured":"Restelli U, Bonfanti M, Croce D, Grau S, Metallidis S, Moreno Guill\u00e9n S, et al. Organisational and financial consequences of the early discharge of patients treated for acute bacterial skin and skin structure infection and osteomyelitis in infectious disease departments in Greece, Italy and Spain: a scenario analysis. BMJ Open. 2019;9(9):e031356.","journal-title":"BMJ Open"},{"issue":"suppl 6","key":"1306_CR38","first-page":"vi25","volume":"66","author":"A Versporten","year":"2011","unstructured":"Versporten A, Coenen S, Adriaenssens N, Muller A, Minalu G, Faes C, et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient cephalosporin use in Europe (1997\u20132009). J Antimicrob Chemother. 2011;66(suppl 6):vi25\u201335.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"1306_CR39","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1179\/joc.2002.14.1.71","volume":"14","author":"L Lazzarini","year":"2002","unstructured":"Lazzarini L, Tramarin A, Bragagnolo L, Tositti G, Manfrin V, Lalla FD. Three-times weekly teicoplanin in the outpatient treatment of acute methicillin-resistant staphylococcal osteomyelitis: a pilot study. J Chemother. 2002;14(1):71\u20135.","journal-title":"J Chemother"},{"issue":"4","key":"1306_CR40","doi-asserted-by":"publisher","first-page":"650","DOI":"10.3390\/jpm12040650","volume":"12","author":"S Di Giambenedetto","year":"2022","unstructured":"Di Giambenedetto S, Borghetti A, Quagliozzi L, Gallucci V, Lombardi F, Ciccullo A, et al. Implementing a personalized Antimicrobial Stewardship Program for women with gynecological cancers and healthcare-associated infections. JPM. 2022;12(4):650.","journal-title":"JPM"},{"issue":"10","key":"1306_CR41","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1080\/23744235.2024.2387130","volume":"56","author":"G Giuliano","year":"2024","unstructured":"Giuliano G, Tarantino D, Tamburrini E, Nurchis MC, Scoppettuolo G, Raffaelli F. Effectiveness and safety of ceftolozane\/tazobactam administered in continuous infusion through elastomeric pumps in OPAT regimen: a case series. Infect Dis. 2024;56(10):887\u201393.","journal-title":"Infect Dis"},{"issue":"2","key":"1306_CR42","first-page":"108","volume":"9","author":"FS Nigro","year":"2001","unstructured":"Nigro FS, Buonopane G, Iandoli M, Matarazzo M, Maio P, Siano F, et al. Preliminary experience with O.P.A.T. (Outpatient parenteral antimicrobial-drug therapy) in infective endocarditis. Infez Med. 2001;9(2):108\u201310.","journal-title":"Infez Med"},{"issue":"Supplement_2","key":"1306_CR43","doi-asserted-by":"publisher","first-page":"ii160","DOI":"10.1093\/eurheartjsupp\/suae036.393","volume":"26","author":"M Di Marino","year":"2024","unstructured":"Di Marino M, Genovesi E, D\u2019Alleva A, Magnano R, Pezzi L, Gallina S, et al. Nosocomial endocarditis on aortic bioprosthesis, a case of accelerated atherosclerosis. Eur Heart J Suppl. 2024;26(Supplement_2):ii160\u2013ii160.","journal-title":"Eur Heart J Suppl"},{"issue":"3","key":"1306_CR44","doi-asserted-by":"publisher","first-page":"dlaf087","DOI":"10.1093\/jacamr\/dlaf087","volume":"7","author":"C Pallotto","year":"2025","unstructured":"Pallotto C, Benvenuto MC, Francisci D. Shoulder prosthetic joint infection due to Pseudomonas aeruginosa and carbapenem-resistant Acinetobacter baumannii treated with ciprofloxacin, minocycline and continuous infusion fosfomycin as OPAT regimen: a case report. JAC-Antimicrob Resist. 2025;7(3):dlaf087.","journal-title":"JAC-Antimicrob Resist."},{"issue":"2","key":"1306_CR45","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/BF03320624","volume":"6","author":"C Lucioni","year":"2004","unstructured":"Lucioni C, Saramin C, Marchetti F. Modalit\u00e0 di prescrizione in Italia degli antibiotici iniettabili e orali nel trattamento delle infezioni delle vie aeree inferiori negli anni 1993\u20132002. Pharmacoeconomics-Ital-Res-Articles. 2004;6(2):59\u201367.","journal-title":"Pharmacoeconomics-Ital-Res-Articles"},{"issue":"Suppl. 1","key":"1306_CR46","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1159\/000048566","volume":"47","author":"S Esposito","year":"2001","unstructured":"Esposito S. Treatment of lower respiratory tract infections in Italy: the role of outpatient parenteral antibiotic therapy. Chemotherapy. 2001;47(Suppl. 1):33\u201340.","journal-title":"Chemotherapy"},{"issue":"3","key":"1306_CR47","first-page":"169","volume":"10","author":"S Esposito","year":"2002","unstructured":"Esposito S, Ianniello F, Noviello S, Leone S, Ascione T, Tice A, et al. Outpatient parenteral antibiotic therapy (OPAT): the Italian registry. Infez Med. 2002;10(3):169\u201375.","journal-title":"Infez Med"},{"issue":"2","key":"1306_CR48","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1179\/joc.2009.21.2.193","volume":"21","author":"S Esposito","year":"2009","unstructured":"Esposito S, Leone S, Noviello S, Ianniello F, Russo M, Foti G, et al. Outpatient parenteral antibiotic therapy in the elderly: an Italian observational multicenter study. J Chemother. 2009;21(2):193\u20138.","journal-title":"J Chemother"},{"issue":"2","key":"1306_CR49","first-page":"137","volume":"24","author":"S Esposito","year":"2016","unstructured":"Esposito S, Noviello S, Boccia G, De Simone G, Pagliano P, De Caro F. Changing modalities of outpatient parenteral antimicrobial therapy use over time in Italy: a comparison of two time periods. Infez Med. 2016;24(2):137\u20139.","journal-title":"Infez Med"},{"issue":"2","key":"1306_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.idnow.2023.01.002","volume":"53","author":"G Giuliano","year":"2023","unstructured":"Giuliano G, Raffaelli F, Faliero D, Tamburrini E, Tarantino D, Nurchis MC, et al. Outpatient parenteral antimicrobial therapy (OPAT) from an emergency model applied during the COVID-19 pandemic to standard of care: preliminary lessons from our experience. Infect Dis Now. 2023;53(2):104642.","journal-title":"Infect Dis Now"},{"issue":"10","key":"1306_CR51","first-page":"581","volume":"42","author":"G Giuliano","year":"2024","unstructured":"Giuliano G, Tarantino D, Tamburrini E, Nurchis MC, Scoppettuolo G, Raffaelli F. Outpatient parenteral antibiotic therapy (OPAT) through elastomeric continuous infusion pumps in a real-life observational study: characteristics, safety, and efficacy analysis. Enfermedades infecciosas y microbiologia clinica (Engl Ed). 2024;42(10):581\u20137.","journal-title":"Enfermedades infecciosas y microbiologia clinica (Engl Ed)"},{"issue":"4","key":"1306_CR52","first-page":"230","volume":"10","author":"A Marvaso","year":"2002","unstructured":"Marvaso A, Esposito S, Noviello S, Ianniello F, Leone S, Maiello A, et al. Outpatient parenteral antibiotic therapy (OPAT) of diabetic foot infections with piperacillin\/tazobactam. Infez Med. 2002;10(4):230\u20135.","journal-title":"Infez Med"},{"key":"1306_CR53","unstructured":"Carlotto A, Ferretto R, Timillero L, Marranconi F. Outpatient parenteral antibiotic therapy for cellulitis. A 10-year single-centre experience. Public health and community-acquired infections. In: 20th European Congress of Clinical Microbiology and Infectious Diseases: S673, 2010."},{"issue":"4","key":"1306_CR54","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1179\/joc.2007.19.4.417","volume":"19","author":"S Esposito","year":"2007","unstructured":"Esposito S, Leone S, Noviello S, Ianniello F, Fiore M, Russo M, et al. Outpatient parenteral antibiotic therapy for bone and joint infections: an Italian multicenter study. J Chemother. 2007;19(4):417\u201322.","journal-title":"J Chemother"},{"issue":"5","key":"1306_CR55","doi-asserted-by":"publisher","first-page":"466","DOI":"10.3390\/antibiotics14050466","volume":"14","author":"E d\u2019Huart","year":"2025","unstructured":"d\u2019Huart E, Boutouha I, Berardi C, Vigneron J, Demore B, Charmillon A. Stability of nine time-dependent antibiotics for outpatient parenteral antimicrobial therapy (OPAT) use. Antibiotics. 2025;14(5):466.","journal-title":"Antibiotics"},{"issue":"8","key":"1306_CR56","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1007\/s40121-025-01174-7","volume":"14","author":"B Esteban-Cartelle","year":"2025","unstructured":"Esteban-Cartelle B, Anaya BJ, P\u00e9rez Men\u00e9ndez-Conde C, Vicente-Oliveros N, Serrano DR, \u00c1lvarez-D\u00edaz A, et al. Stability of ceftobiprole medocaril in portable elastomeric infusion devices. Infect Dis Ther. 2025;14(8):1685\u201396.","journal-title":"Infect Dis Ther"},{"issue":"7","key":"1306_CR57","first-page":"399","volume":"40","author":"LE L\u00f3pez-Cort\u00e9s","year":"2022","unstructured":"L\u00f3pez-Cort\u00e9s LE, Herrera-Hidalgo L, Almadana V, Gil-Navarro MV. Ceftobiprole, a new option for multidrug-resistant microorganisms in the outpatient antimicrobial therapy setting. Enfermedades infecciosas y microbiologia clinica (Engl Ed). 2022;40(7):399\u2013400.","journal-title":"Enfermedades infecciosas y microbiologia clinica (Engl Ed)"},{"issue":"4","key":"1306_CR58","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1080\/14787210.2023.2184347","volume":"21","author":"JA Roberts","year":"2023","unstructured":"Roberts JA, Croom K, Adomakoh N. Continuous infusion of beta-lactam antibiotics: narrative review of systematic reviews, and implications for outpatient parenteral antibiotic therapy. Expert Rev Anti Infect Ther. 2023;21(4):375\u201385.","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"9","key":"1306_CR59","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1093\/jac\/dky224","volume":"73","author":"R Voumard","year":"2018","unstructured":"Voumard R, Gardiol C, Andr\u00e9 P, Arensdorff L, Cochet C, Boillat-Blanco N, et al. Efficacy and safety of continuous infusions with elastomeric pumps for outpatient parenteral antimicrobial therapy (OPAT): an observational study. J Antimicrob Chemother. 2018;73(9):2540\u20135.","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"1306_CR60","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2024-084727","volume":"14","author":"AR Burch","year":"2024","unstructured":"Burch AR, Ledergerber B, Ringer M, Zinkernagel AS, Eberhard N, Kaelin MB, et al. Patient-reported outcome measures in an outpatient parenteral antimicrobial therapy program: a prospective cohort study. BMJ Open. 2024;14(12):e084727.","journal-title":"BMJ Open"},{"issue":"12","key":"1306_CR61","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz471","volume":"6","author":"O Mansour","year":"2019","unstructured":"Mansour O, Arbaje AI, Townsend JL. Patient experiences with outpatient parenteral antibiotic therapy: results of a patient survey comparing skilled nursing facilities and home infusion. Open Forum Infect Dis. 2019;6(12):ofz471. https:\/\/doi.org\/10.1093\/ofid\/ofz471","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"1306_CR62","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1093\/jac\/dku401","volume":"70","author":"S Patel","year":"2015","unstructured":"Patel S, Abrahamson E, Goldring S, Green H, Wickens H, Laundy M. Good practice recommendations for paediatric outpatient parenteral antibiotic therapy (p-OPAT) in the UK: a consensus statement. J Antimicrob Chemother. 2015;70(2):360\u201373.","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"1306_CR63","doi-asserted-by":"publisher","first-page":"ofaa205","DOI":"10.1093\/ofid\/ofaa205","volume":"7","author":"Y Hamad","year":"2020","unstructured":"Hamad Y, Dodda S, Frank A, Beggs J, Sleckman C, Kleinschmidt G, et al. Perspectives of patients on outpatient parenteral antimicrobial therapy: experiences and adherence. Open Forum Infect Dis. 2020;7(6):ofaa205.","journal-title":"Open Forum Infect Dis"},{"issue":"9","key":"1306_CR64","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1093\/jac\/dkr253","volume":"66","author":"MJ Talpaert","year":"2011","unstructured":"Talpaert MJ, Gopal Rao G, Cooper BS, Wade P. Impact of guidelines and enhanced antibiotic stewardship on reducing broad-spectrum antibiotic usage and its effect on incidence of Clostridium difficile infection. J Antimicrob Chemother. 2011;66(9):2168\u201374.","journal-title":"J Antimicrob Chemother"},{"key":"1306_CR65","doi-asserted-by":"publisher","unstructured":"Reigadas E, V\u00e1zquez-Cuesta S, Bouza E. Economic burden of Clostridioides difficile infection in European Countries. In: Mastrantonio P, Rupnik M, editors. Updates on Clostridioides difficile in Europe [Internet]. Cham: Springer International Publishing; 2024 [cited 2025 Dec 14]. p. 1\u201312. (Advances in experimental medicine and biology; vol. 1435). Available from: https:\/\/doi.org\/10.1007\/978-3-031-42108-2_1.","DOI":"10.1007\/978-3-031-42108-2_1"},{"issue":"1","key":"1306_CR66","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.ijantimicag.2017.02.017","volume":"50","author":"VJ Gonz\u00e1lez-Ramallo","year":"2017","unstructured":"Gonz\u00e1lez-Ramallo VJ, Mir\u00f3n-Rubio M, Mujal A, Estrada O, Forn\u00e9 C, Arag\u00f3n B, et al. Costs of outpatient parenteral antimicrobial therapy (OPAT) administered by hospital at home units in Spain. Int J Antimicrob Agents. 2017;50(1):114\u20138.","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"1306_CR67","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3390\/pharmacy8040233","volume":"8","author":"T Docherty","year":"2020","unstructured":"Docherty T, Schneider JJ, Cooper J. Clinic- and hospital-based home care, outpatient parenteral antimicrobial therapy (OPAT) and the evolving clinical responsibilities of the pharmacist. Pharmacy. 2020;8(4):233.","journal-title":"Pharmacy"},{"issue":"11","key":"1306_CR68","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1345\/aph.1Q240","volume":"45","author":"BH Heintz","year":"2011","unstructured":"Heintz BH, Halilovic J, Christensen CL. Impact of a multidisciplinary team review of potential outpatient parenteral antimicrobial therapy prior to discharge from an academic medical center. Ann Pharmacother. 2011;45(11):1329\u201337.","journal-title":"Ann Pharmacother"},{"key":"1306_CR69","volume":"11","author":"M Ibaraki","year":"2024","unstructured":"Ibaraki M, Gruss Z, Wings E, Geronimo JE, Varnes JM, Kammeyer JA. Impact of a nurse practitioner-led dedicated outpatient parenteral antibiotic therapy clinic on patient outcomes and administrative workload: a retrospective cohort study. Ther Adv Infect Dis. 2024;11:20499361241305308.","journal-title":"Ther Adv Infect Dis"},{"issue":"8","key":"1306_CR70","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1007\/s40121-025-01182-7","volume":"14","author":"M Yousif","year":"2025","unstructured":"Yousif M, Geriak M, Vasina L, Sakoulas G. Risk factors for hospital readmission following outpatient parenteral antimicrobial therapy (OPAT). Infect Dis Ther. 2025;14(8):1989\u201395.","journal-title":"Infect Dis Ther"}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-026-01306-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-026-01306-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-026-01306-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T04:36:24Z","timestamp":1775104584000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-026-01306-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,9]]},"references-count":70,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["1306"],"URL":"https:\/\/doi.org\/10.1007\/s40121-026-01306-7","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,9]]},"assertion":[{"value":"5 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Chiara Moreal, Simone Giuliano, Francesca Prataviera, Massimo Fantoni, Sergio Mezzadri, Valentina Menozzi, Meri Marin, Raul Cetatean, Elena Sora, Elena Rosselli Del Turco, Fabio Tumietto, Cristina Moracas, Alfredo Guarino, Riccardo Vecchio, Anna Odone, Vilma Urban\u010di\u010d, Alvisa Palese and Carlo Tascini declared no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}